Industry Symposia
Saturday, 17 April 2021
12:00 – 13:15 (CET)
Industry Symposium Sanofi Genzyme / Regeneron
Impacto de la inflamación de Tipo 2 en la vía aérea. Una visión multidisciplinar / Impact of Type 2 inflammation on the airways. A multidisciplinary vision
* Please note: This Industry Session will be offered in Spanish
Bienvenida / Welcome, Antonio Valero
Visión del alergólogo de la vía aérea única: El asma y sus comorbilidades / Respiratory airway from Allergist’s perspective: asthma and its comorbidities, Jose Maria Vega Chicote
Visión del otorrino de la vía aérea única: La RSCcPN y sus comorbilidades / ENT’s view of the respiratory airway: CRSRN and its comorbidities, Alfonso del Cuvillo
Debate y preguntas / Questions and Discussion, Antonio Valero, Jose Maria Vega Chicote, Alfonso del Cuvillo
13:30 – 14:45 (CET)
Industry Symposium Sanofi Genzyme / Regeneron
Dupilumab for the Treatment of Type 2 Airway Diseases: Expert Panel Discussion of Clinical Evidence and Experienc
Opening Remarks & Panel Introductions, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek
Type 2 Inflammation in Diseases of the Upper and Lower Airway, Mona Al-Ahmad
Review of the Evidence for Dupilumab: Asthma, G. Walter Canonica
Review of the Evidence for Dupilumab: CRSwNP, Ludger Klimek
Panel Discussion and Audience Q&A, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek
Clinical Experience With Dupilumab for the Treatment of Severe Type 2 Asthma and CRSwNP, Mona Al-Ahmad, Ludger Klimek
Audience Q&A and Closing Remarks, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek